Improving platinum(II)-based anticancer drug delivery using cucurbit[n]urils

N.J. Wheate

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

Despite the synthesis of hundreds of new platinum(II) and platinum(IV)-based complexes each year as potential anticancer drugs, only three have received world-wide approval: cisplatin, carboplatin and oxaliplatin. The next big advance in platinum-based chemotherapy is not likely to come from the development of new drugs, but from the controlled and targeted delivery of already approved drugs or those in late stage clinical trials. Encapsulation of platinum drugs inside macromolecules has already demonstrated promise, and encapsulation within cucurbit[n]urils has shown particular potential. Partial or full encapsulation within cucurbit[n]urils provides steric hindrance to drug degradation by peptides and proteins, and the use of different sized cucurbit[n]urils allows for the tuning of drug release rates, cytotoxicity and toxicity.
LanguageEnglish
Pages2060-2066
Number of pages6
JournalJournal of Inorganic Biochemistry
Volume102
Issue number12
DOIs
Publication statusPublished - 2008

Fingerprint

Platinum
Drug delivery
Encapsulation
oxaliplatin
Pharmaceutical Preparations
Carboplatin
Drug-Related Side Effects and Adverse Reactions
Chemotherapy
Cisplatin
Proteolysis
Cytotoxicity
Macromolecules
Toxicity
Clinical Trials
Drug Therapy
Tuning
Peptides
Degradation
Proteins

Keywords

  • Platinum
  • Cucurbituril
  • Cancer
  • Drug delivery
  • cytotoxicity
  • toxicity
  • cisplatin
  • oxaliplatin
  • BBR3464
  • BBR3571

Cite this

@article{eab0a624938e4ba1a7f70ea2eba3d548,
title = "Improving platinum(II)-based anticancer drug delivery using cucurbit[n]urils",
abstract = "Despite the synthesis of hundreds of new platinum(II) and platinum(IV)-based complexes each year as potential anticancer drugs, only three have received world-wide approval: cisplatin, carboplatin and oxaliplatin. The next big advance in platinum-based chemotherapy is not likely to come from the development of new drugs, but from the controlled and targeted delivery of already approved drugs or those in late stage clinical trials. Encapsulation of platinum drugs inside macromolecules has already demonstrated promise, and encapsulation within cucurbit[n]urils has shown particular potential. Partial or full encapsulation within cucurbit[n]urils provides steric hindrance to drug degradation by peptides and proteins, and the use of different sized cucurbit[n]urils allows for the tuning of drug release rates, cytotoxicity and toxicity.",
keywords = "Platinum, Cucurbituril, Cancer, Drug delivery, cytotoxicity, toxicity, cisplatin, oxaliplatin, BBR3464, BBR3571",
author = "N.J. Wheate",
note = "http://suprimo.lib.strath.ac.uk/primo_library/libweb/action/display.do?ct=display&doc=SUSFX954925478535&indx=1&frbg=&dum=true&vid=SUVU01&vl(54032236UI0)=lsr02&vl(96071691UI1)=all_items&srt=rank&indx=1&dstmp=1274087493379&tab=local&ct=search&scp.scps=scope{\%}3A(SU)&vl(freeText0)=Journal{\%}20of{\%}20Inorganic{\%}20Biochemistry&fn=search&mode=Basic&dscnt=0",
year = "2008",
doi = "10.1016/j.jinorgbio.2008.06.005",
language = "English",
volume = "102",
pages = "2060--2066",
journal = "Journal of Inorganic Biochemistry",
issn = "0162-0134",
number = "12",

}

Improving platinum(II)-based anticancer drug delivery using cucurbit[n]urils. / Wheate, N.J.

In: Journal of Inorganic Biochemistry, Vol. 102, No. 12, 2008, p. 2060-2066.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Improving platinum(II)-based anticancer drug delivery using cucurbit[n]urils

AU - Wheate, N.J.

N1 - http://suprimo.lib.strath.ac.uk/primo_library/libweb/action/display.do?ct=display&doc=SUSFX954925478535&indx=1&frbg=&dum=true&vid=SUVU01&vl(54032236UI0)=lsr02&vl(96071691UI1)=all_items&srt=rank&indx=1&dstmp=1274087493379&tab=local&ct=search&scp.scps=scope%3A(SU)&vl(freeText0)=Journal%20of%20Inorganic%20Biochemistry&fn=search&mode=Basic&dscnt=0

PY - 2008

Y1 - 2008

N2 - Despite the synthesis of hundreds of new platinum(II) and platinum(IV)-based complexes each year as potential anticancer drugs, only three have received world-wide approval: cisplatin, carboplatin and oxaliplatin. The next big advance in platinum-based chemotherapy is not likely to come from the development of new drugs, but from the controlled and targeted delivery of already approved drugs or those in late stage clinical trials. Encapsulation of platinum drugs inside macromolecules has already demonstrated promise, and encapsulation within cucurbit[n]urils has shown particular potential. Partial or full encapsulation within cucurbit[n]urils provides steric hindrance to drug degradation by peptides and proteins, and the use of different sized cucurbit[n]urils allows for the tuning of drug release rates, cytotoxicity and toxicity.

AB - Despite the synthesis of hundreds of new platinum(II) and platinum(IV)-based complexes each year as potential anticancer drugs, only three have received world-wide approval: cisplatin, carboplatin and oxaliplatin. The next big advance in platinum-based chemotherapy is not likely to come from the development of new drugs, but from the controlled and targeted delivery of already approved drugs or those in late stage clinical trials. Encapsulation of platinum drugs inside macromolecules has already demonstrated promise, and encapsulation within cucurbit[n]urils has shown particular potential. Partial or full encapsulation within cucurbit[n]urils provides steric hindrance to drug degradation by peptides and proteins, and the use of different sized cucurbit[n]urils allows for the tuning of drug release rates, cytotoxicity and toxicity.

KW - Platinum

KW - Cucurbituril

KW - Cancer

KW - Drug delivery

KW - cytotoxicity

KW - toxicity

KW - cisplatin

KW - oxaliplatin

KW - BBR3464

KW - BBR3571

UR - http://dx.doi.org/10.1016/j.jinorgbio.2008.06.005

U2 - 10.1016/j.jinorgbio.2008.06.005

DO - 10.1016/j.jinorgbio.2008.06.005

M3 - Article

VL - 102

SP - 2060

EP - 2066

JO - Journal of Inorganic Biochemistry

T2 - Journal of Inorganic Biochemistry

JF - Journal of Inorganic Biochemistry

SN - 0162-0134

IS - 12

ER -